Metabolic syndrome among people living with HIV on antiretroviral therapy in Mwanza, Tanzania

HIV and antiretroviral drugs, particularly protease inhibitors and nucleoside reverse transcriptase inhibitors, may increase the risk of Metabolic Syndrome (MetS) among people living with HIV (PLHIV). However,...

Source: BMC Endocrine Disorders - April 21, 2023 Category: Endocrinology Authors: Evangelista Malindisa, Emmanuel Balandya, Marina Njelekela, Benson R. Kidenya, Filbert Francis, Blandina T. Mmbaga, Haruna Dika, Eligius Lyamuya, Bruno Sunguya, John Bartlett and George PrayGod Tags: Research Source Type: research